[HTML][HTML] EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
B Youngblood, JC Medina, DR Gehlert… - Frontiers in …, 2023 - frontiersin.org
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-
resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients) …
resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients) …
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors
B Youngblood, JC Medina, DR Gehlert… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-
resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients) …
resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients) …
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive-compulsive disorder (OCD)-like behaviors.
B Youngblood, JC Medina, DR Gehlert… - Frontiers in …, 2023 - europepmc.org
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-
resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients) …
resistant obsessive-compulsive disorder (OCD) patients (10-50% of OCD patients) …
[HTML][HTML] EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
B Youngblood, JC Medina, DR Gehlert… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-
resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients) …
resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients) …